The effect of ANRIL expression on cancer cell proliferation observed in our study is consistent with previous reports documented in retinoblastoma, liver cancer, gastric cancer and lung cancer [30,31,32,33,34,35,36]. Here, CDKN2B-AS1 is linked to liver cancer.